Skip to: Content
Skip to: Site Navigation
Skip to: Search

September 5, 2008 7:04:59 AM CDT

Learn about Newser Points »

Stories related to: medicine

Stories

Stories 61 - 80 of 108

<< Prev 1 2 3 4 5 6 Next >>
  • June 2007

    • Americans Go Abroad, Online for New Diet Pill

      Bloomberg  |  Jun 11, 07 8:21 PM CDT

      Americans Go Abroad, Online for New Diet Pill

      (Newser) - The weight loss drug Acomplia is stuck in FDA limbo, but that isn't stopping Americans from ordering it off the Internet or buying it in Europe, where it's legal. If the government rules that its lowering of weight and cholesterol balances out the possible side effects, including suicide and depression, Acomplia could be worth billions to manufacturer Sanofi-Aventis. More »

      Tags

      medicine  • FDA  • suicide  • depression  • weight loss  • obesity epidemic  • cholesterol  • diet pills  • Sanofi Aventis  • Acomplia

    • Genes Give Up Secrets of 7 Serious Diseases

      BBC  |  Jun 7, 07 8:18 AM CDT

      Genes Give Up Secrets of 7 Serious Diseases

      (Newser) - In an outcome one scientist describes as a "new dawn," researchers have identified genetic variations linked to seven common diseases, opening the door to improved tests and treatments. The study, which focused on depression, Crohn's disease, coronary artery disease, hypertension, rheumatoid arthritis, and Type 1 and 2 diabetes, also found unexpected links between some of the ailments. More »

      Tags

      health  • medicine  • heart disease  • disease  • genetics  • diabetes  • depression  • hypertension  • rheumatoid arthritis  • Crohn's disease

    • Controversy Rages Over Diabetes Drug's Heart Risks

      New York Times  |  Jun 6, 07 12:16 PM CDT

      Controversy Rages Over Diabetes Drug's Heart Risks

      (Newser) - Troubling questions about the diabetes drug Avandia persisted yesterday as an FDA official revealed that she was barred from recommending a critical warning about the medication, the Times reports. In the run-up to congressional hearings that began today, manufacturer GlaxoSmithKline rushed to disseminate interim clinical findings in hopes of blunting the controversy. More »

      Tags

      health  • medicine  • FDA  • diabetes  • heart attack  • heart  • GlaxoSmithKline  • Avandia

    • Nigeria Sues Pfizer Over Deadly Tests

      BBC  |  Jun 5, 07 12:35 PM CDT

      Nigeria Sues Pfizer Over Deadly Tests

      (Newser) - Nigeria is suing pharma giant Pfizer for $7 billion, claiming the company carried out improper trials on children. 200 children in the state of Kano died, and others developed deformities, after Pfizer tested Trovan, an experimental antibiotic, during a 1996 meningitis outbreak. Nigeria claims the tests were unauthorized, but Pfizer insists the company had consent. More »

      Tags

      children  • medicine  • Nigeria  • Pfizer  • pharma  • meningitis

    • UK to Patients Who Smoke: Put That Out

      Daily Mail (UK)  |  Jun 4, 07 3:49 PM CDT

      UK to Patients Who Smoke: Put That Out

      (Newser) - Smokers in Britain must kick the habit for at least four weeks before undergoing routine surgery or the National Health Service will deny them the operations, the Daily Mail reports. Doctors will use blood tests to enforce the new policy, which could affect up to 500,000 smokers awaiting procedures for non-life-threatening conditions each year. More »

      Tags

      Great Britain  • health  • medicine  • England  • smoking  • surgery  • smoking ban  • patient

    • New Drug Battles Liver Cancer

      New York Times  |  Jun 4, 07 7:37 AM CDT

      New Drug Battles Liver Cancer

      (Newser) - An impressive clinical trial has produced what could be the first effective drug treatment for liver cancer, the New York Times reports. Nexavar, which blocks both the blood supply to the tumor and proteins that spur tumor growth, extended the lives of patients in the trial by almost three months, or 44% More »

      Tags

      health  • cancer  • drugs  • medicine  • treatment  • cancer treatment  • tumor  • liver cancer

    • Kidney Donor Reality Show Was a Hoax

      Guardian (UK)  |  Jun 2, 07 10:48 AM CDT

      Kidney Donor Reality Show Was a Hoax

      (Newser) - A controversial Dutch reality show featuring a dying woman’s choice of a kidney recipient aired last night—and was revealed as a hoax. The "donor" was an actor; the contestants were real patients who were in on the prank. A producer said the goal was to call attention to the shortage of donor organs, adding, "We have succeeded in spades." More »

      Tags

      health care  • medicine  • reality TV  • organ transplants  • organ donor  • The Big Donor Show  • Endemol

  • May 2007

    • Glaxo Stems Stock Slide Over Avandia

      Daily Telegraph (UK)  |  May 31, 07 6:44 AM CDT

      Glaxo Stems Stock Slide Over Avandia

      (Newser) - Glaxo shares pulled out of a tailspin after the pharma giant defended its second biggest selling drug, Avandia, against claims that it triggers heart attacks.  A sharply worded letter from the company's chief medical officer on the website of medical journal The Lancet pointed out that the increased incidence of heart attacks among Avandia patients—0.6%—was still very small. More »

      Tags

      drugs  • medicine  • diabetes  • heart attack  • GlaxoSmithKline  • Avandia  • pharma

    • Drug-Resistant TB Patient Flies Commercial

      CNN  |  May 30, 07 6:02 AM CDT

      Drug-Resistant TB Patient Flies Commercial

      (Newser) - A man infected with drug-resistant tuberculosis boarded two transatlantic flights in two weeks, CNN reports, putting his fellow passengers at risk. Planes are equipped with air filters that should catch the rod-shaped TB bacili, but the CDC recommends anyone on Air France 385, from Atlanta to Paris May 12, or Czech Air 0104, Prague to Montreal May 24, get tested. More »

      Tags

      health  • France  • medicine  • safety  • infection  • Czech Republic  • Tuberculosis

    • Eye-Care Recall Reverberates on Wall Street

      MarketWatch  |  May 29, 07 1:24 PM CDT

      Eye-Care Recall Reverberates on Wall Street

      (Newser) - In the wake of reports linking its Complete MoisturePlus contact lens solution to a rare eye infection that can lead to blindness, Advanced Medical Optics has recalled the product. Competitor Bausch & Lomb's stock price dropped on the news, since the recall may put AMO's plans to enter the bidding war for B&L in jeopardy. More »

      Tags

      medicine  • infection  • CDC  • blindness  • eye care  • Bausch and Lomb  • contact lenses

    • Scientists ID New Breast Cancer Genes

      Guardian (UK)  |  May 28, 07 7:11 AM CDT

      Scientists ID New Breast Cancer Genes

      (Newser) - Four newly discovered genes can increase a woman's chance of developing breast cancer by as much as 60%, say scientists who hail the isolation of the genes as the biggest advance in the field since 1994. The breakthrough raises hopes for more advanced treatment and even prevention of breast cancer and for better understanding of other cancers in the future. More »

      Tags

      health  • cancer  • medicine  • women  • breast cancer  • research  • cancer research  • women's health  • genes  • treatment

    • New Cancer Ideas Compete for $1 Million

      Reuters  |  May 23, 07 5:39 PM CDT

      New Cancer Ideas Compete for $1 Million

      (Newser) - Doctors and hedge fund managers are joining forces to battle cancer with a million-dollar prize for the most imaginative new approach. The Gotham Prize for Cancer Research will be awarded to the most innovative essay—posted to the website—on finding a cure for cancer. Leading medical researchers will judge the submissions at year's end. More »

      Tags

      health  • cancer  • medicine  • hedge fund  • cancer research  • innovation  • Harvard Medical School

    • Drug Company Nemesis Strikes Again

      Wall Street Journal  |  May 22, 07 1:32 PM CDT

      Drug Company Nemesis Strikes Again

      (Newser) - The doctor who helped to raise concerns about the painkiller Vioxx is back—with the study released earlier this week linking the same company's popular diabetes drug, Avandia, to higher risk of heart attacks. The Wall Street Journal looks at 58-year-old cardiologist Steven Nissen's role in identifying and publicizing drug risks. More »

      Tags

      drugs  • medicine  • FDA  • diabetes  • pharmaceutical companies  • GlaxoSmithKline  • Avandia  • Vioxx

    • Diabetes Drug Ups Heart Risk

      Associated Press  |  May 21, 07 3:15 PM CDT

      Diabetes Drug Ups Heart Risk

      (Newser) - A popular diabetes drug may increase heart attack risks, a study reported in the New England Journal of Medicine concludes. Patients who took Avandia, which treats Type 2 diabetes, were 43% more likely to have a heart attack than those who took a placebo, the Cleveland Clinic study found. More »

      Tags

      health  • medicine  • FDA  • medical research  • diabetes  • heart attack  • pharmaceutical companies  • GlaxoSmithKline  • Avandia  • pharma

    • Psych Drugs Drove Kid Crazy

      Salon  |  May 18, 07 9:44 PM CDT

      Psych Drugs Drove Kid Crazy

      (Newser) - The careless prescription of anti-psychotic drugs, often by psychiatrists who draw pay checks from the companies who make them, has drawn attention in the New York Times recently. Now Ann Bauer, writing in Salon , draws an intimate portrait of the effects of such carelessness on one autistic teenager, who turned from shy chess nerd to psychotic bruiser. More »

      Tags

      health  • drugs  • medicine  • doctor  • pharmaceutical companies  • drug companies  • psychiatry  • schizophrenia  • pharma  • antipsychotic drugs

    • Britain OKs Human-Animal Hybrids for Research

      Guardian (UK)  |  May 17, 07 2:31 PM CDT

      Britain OKs Human-Animal Hybrids for Research

      (Newser) - The British government has reversed its stance on the creation of human-animal hybrid embryos and will propose allowing scientists to use them as sources of stem cells. Scientists developing treatments for incurable diseases would be allowed to grow the hybrid embryos for no longer than two weeks, and implanting them into a human womb would not be permitted. More »

      Tags

      health  • medicine  • research  • medical breakthrough  • stem cells  • stem cell research  • embryo  • hybrid animal

    • Big Pharma Loses Generic Drug Fight

      Wall Street Journal  |  May 17, 07 10:23 AM CDT

      Big Pharma Loses Generic Drug Fight

      (Newser) - Congress and the White House have agreed to give developing nations more access to affordable generic drugs by easing some patent enforcement rules. Tucked into a broader trade agreement passed last week, the provision is the first blow to American pharmaceutical companies since the Democrats won control of Congress, the Wall Street Journal reports. More »

      Tags

      health  • drugs  • health care  • medicine  • prescription drugs  • pharmaceutical companies  • Medicare  • pharma

    • Spider Venom the New Viagra

      Der Spiegel  |  May 16, 07 7:31 AM CDT

      Spider Venom the New Viagra

      (Newser) - Men with erectile dysfunction may get an assist, believe it or not, from the Brazillian wandering spider—also dubbed the banana spider for its propensity to hide in bunches of the fruit. Researchers at Johns Hopkins have isolated a compound in the spider's deadly saliva that causes erections, der Spiegel reports. More »

      Tags

      health  • medicine  • Viagra  • erectile dysfunction  • Levitra  • Cialis

    • OxyContin Maker Pleads Guilty

      Associated Press  |  May 10, 07 12:01 PM CDT

      OxyContin Maker Pleads Guilty

      (Newser) - The company that makes OxyContin pleaded guilty today to misleading the public about the effects of the potent painkiller. Purdue Pharma and three executives will pay $634.5 million in civil and criminal fines. Federal prosecutors accused the firm of "misbranding" the drug, marketing it as a less addictive alternative to traditional pain meds although no evidence supported the claim. More »

      Tags

      health  • lawsuit  • crime  • medicine  • prescription drugs  • OxyContin

    • Use of Antipsychotics For Kids Soars

      New York Times  |  May 10, 07 10:23 AM CDT

      (Newser) - The Times tackles the growing use of antipsychotic drugs in children, contentious because the drugs are risky and have no approved use for minors. But the trend is also questionable because it coincides with increasing payments to psychiatrists by the companies that market the drugs. In Minnesota, these payments rose sixfold from 2000 to 2005. More »

      Tags

      children  • medicine  • safety  • drug companies  • psychiatry  • antipsychotic drugs

Stories 61 - 80 of 108

<< Prev 1 2 3 4 5 6 Next >>

Today's Most Popular

Premium Articles from HighBeam

Find more articles like this

What is Newser?

2008 Codie Finalist

Newser gives you more news in less time. We search for the best and most important stories all over the web, read them for you, and deliver concise and sharp summaries—along with links to the full text. Newser provides a way to stay on top of an ever-expanding horizon of news and opinion—politics, sports, business, trends, technology, personalities, crimes, and controversies. Newser keeps you not just better informed, but, with our signature graphic interface and smart condensed format, more enjoyably informed.

Learn more »